T he lack of an effective medical therapy that promotes longterm recovery after stroke represents a substantial clinical burden, and so establishes a need for a medical treatment outside the confines of conventional therapies 1 . In the developing body, angiogenesis pioneers a vascular network that leads to the growth and maturation of the nervous system 2 . Angiogenesis after stroke is associated with better outcomes in stroke patients 1 and promotes the formation of neurons through an endogenous neural stem cell response (post-stroke neurogenesis) 3, 4 . However, therapeutic manipulation of angiogenesis in the brain is problematic. The most dominant angiogenic growth factor, the vascular endothelial growth factor (VEGF), is associated with an increase in the blood-brain barrier (BBB) opening, brain oedema and neurological deficits 5 . Other attempts to stimulate brain angiogenesis to promote recovery in stroke have also not been successful 6 . We sought to determine if a therapeutic angiogenic material that delivered an engineered presentation of VEGF directly to the stroke cavity could stimulate angiogenesis and accompanying tissue repair after stroke.
Stroke causes tissue damage and the formation of a cavity. In this cavity, no extracellular matrix supports cell infiltration into the lesion or physically supports a growing tissue 7 . Indeed, there is a glial barrier to cell entry 8 . Stroke also stimulates a massive local inflammatory response that may impede recovery 9 . Over time the cavity reorganizes into a fibrotic scar devoid of neural tissue 10 . Yet, the stroke cavity represents a potential transplant location because it can accept a large volume of injection without affecting normal brain [11] [12] [13] [14] . In addition, the delivery of therapies to the stroke cavity targets the area adjacent to stroke, the peri-infarct area, the site of the most robust neuronal and vascular plasticity after stroke 15 . A successful strategy for brain repair after stroke would deliver a molecule that stimulates angiogenesis and neural regeneration, reduces local inflammation, removes the barrier to cellular infiltration in the stroke site and introduces a scaffold that can serve as a physical support onto which a neuronal network can grow. Recent advances in biopolymer hydrogels have developed materials with extracellular matrix motifs that directly support survival and cell infiltration 16, 17 .
Given that the brain extracellular matrix is composed mostly of glycosaminoglycans and is devoid of fibrous extracellular matrix components 18 , we chose to use an amorphous non-fibrous hydrogel composed of hyaluronic acid (HA), which has been shown to promote neural differentiation 19 , to serve as the backbone into which a VEGF delivery system would serve as the initial physical support for infiltrating cells, angiogenesis and axonogenesis. We previously published a hydrogel-encapsulating soluble brain-derived neurotrophic factor that aimed to promote axonal ingrowth within the damaged site independently of a vascular route 20 . The results showed modest behavioural improvement and no tissue regeneration within the lesion site.
Injectable hydrogel for brain repair
An in situ gelling HA hydrogel (Supplementary Figs. 1 and 2a) that is both hyaluronidase degradable and matrix metalloproteinase (MMP) degradable (Supplementary Figs. 1 and 2a) was selected as the scaffold in which to build an artificial extracellular matrix to promote brain repair after stroke. Injection into the stoke cavity and in situ gelation 5 days after stroke did not significantly affect the cortex volume, size or shape compared to the contralateral side at 2 weeks post-stroke ( Supplementary Fig. 3 ), which indicates that the injection volume (6 µ l) and crosslinked hydrogel could be accommodated by the stroke cavity. Furthermore, injection of this hydrogel resulted in a statistically decreased astrocyte activation ( Supplementary Fig. 4 ) compared to a sham condition. However, this decrease in astrocyte scar thickness was not accompanied with an increase in brain repair as measured by angiogenesis, axonogenesis and behavioural improvement, which indicates that additional factors are required. We previously investigated slow VEGF release formulations ( Supplementary Fig. 5 ) and showed that, although there is an increase in vascularization and pericytes within the stroke cavity, this formulation did not result in an improved neuronal tissue repair, which indicates that, in the context of stroke, the sustained release of VEGF is not sufficient to promote neurological tissue repair. 
Dual-function injectable angiogenic biomaterial

Articles
NATure MATerIAlS
Heparin nanoparticles alter post-stroke inflammation
We designed heparin nanoparticles (nH) so that they retained their ability to bind growth factors 21 , which included VEGF, but did not retain the native heparin ability to reduce blood coagulation ( Supplementary Fig. 6 ). The dominant poststroke inflammatory response of the brain is defined by the activation and recruitment of macrophages and microglia to the damaged site 9 . The initial extent of stroke damage correlates with the intensity of microglia and/or macrophage activation in peri-infarct tissues 22 . HA gel + nH injection into the stroke cavity in distal middle cerebral artery occlusion (MCAo) significantly decreases the microglial and/or macrophage levels (measured by ionized calcium-binding adapter molecule 1 (Iba-1)) as compared to empty gel or sham controls ( Supplementary  Fig. 4 ). The decrease in markers of inflammation was accompanied by a significantly increased vascularization within the stroke cavity and the peri-infarct area (Figs. 1a-d and 2a,b,d ) and an increase in the immature neuron doublecortin (Dcx)-positive cell number (Fig. 3c) . Recent evidence indicates that astrocyte activation in stroke and central nervous system lesions occurs in direct response to the initial damage and restricts this damage 23, 24 , which provides a barometer of the evolving ischaemic injury. nH significantly reduces the region of reactive astrocytes around the stroke cavity ( Supplementary Fig. 4b ). These gels do not modify the size of the stroke lesion itself ( Supplementary Fig. 3d ), which suggests that nH gel delivery to the stroke cavity reduces measures of long-term damage in the tissue that borders the infarct. However, there was no difference of the ingrowth of axons within or around the stroke cavity in this condition.
VeGF clusters differentially activate endothelial cells
The HA gel was further engineered to promote angiogenesis. VEGF, bound to the extracellular matrix, signals through the clustering of VEGF receptors, which leads to a sustained VEGF receptor-2 (VEGFR-2) activation and altered downstream signalling compared to non-matrix-bound VEGF 25 . An increase of ligand avidity through ligand clustering can enhance cellular activation to produce a more controlled tissue morphogenesis than with soluble factors 26 . Different clustering densities of VEGF were synthesized: low, medium and high cluster (lcV, mcv and hcV, respectively ( Supplementary Figs. 1 and 2a-d) ). All the VEGF clustering densities promoted the same level of endothelial cell proliferation ( Supplementary Fig. 2e) ; however, the VEGFR-2 activation was significantly different between the different VEGF clustering densities. Y1175 and Y1214 in VEGFR-2 are major phosphorylation sites and we have previously shown a differential activation upon presentation with bound or soluble VEGF (Vs) 27 . These sites are also associated with the activation of the downstream signalling mitogen-activated protein kinases Erk1/2 (p42/44) and p38 (ref. 28 ). Phosphorylation at Y1175 and Y1214 by clustered VEGF displayed statistically higher phosphorylation for hcV than for mcV or lcV (P < 0.05 ( Supplementary Fig. 2f-h) ) in response to a five-minute exposure to nH-bound VEGF. There was no statistically significant difference between hcV and Vs phosphorylation at Y1175 or Y1214. Interestingly, although no differences in downstream signal activation were observed for the different clustered VEGF presentations, there were differences when compared to Vs-induced activation: Vs preferentially activated p42/44, whereas clustered VEGF preferentially activated p38. The differences in downstream signal are reminiscent of what was observed for collagen-bound and heparinbound VEGF versus Vs [29] [30] [31] , which indicates that VEGF bound to nH responds similarly to VEGF bound to bulk matrices.
hcV results in long-term brain revascularization
The brain tissue response to the angiogenic biomaterial (HA gel + hcV) was assessed after injection into the stroke cavity in distal MCAo 5 days poststroke ( Supplementary Fig 1) . Angiogenesis was measured at 2-and 16-weeks poststroke, which represent a vessel maturation period and a chronic period in tissue and behavioural recovery in stroke, respectively. At 2 weeks after stroke, mice injected with HA gel that contained the hcV condition (HA gel + hcV) significantly increased the endothelial cell area and proliferation (glucose transporter 1 (Glut-1)) and pericyte (plateletderived growth factor receptor-β (PDGFR-β )) area in and around the stroke cavity (Fig. 1a-f ) compared to HA gel that contained the lcV, nH, Vs or HA gel only. The nH-only group also outperformed every other group, but was significantly lower than the hcV condition. As VEGF delivery to the brain has previously been associated with immature vessels that lack pericyte coverage 32 , we tested whether endothelial and pericyte markers were colocalized. We found that HA gel + hcV stimulated the vascular structures with a pericyte coverage (Fig. 1f) . In addition, the quantification of angiopoietin-2, known to play a distinct role in angiogenesis and in the coupling of angiogenesis to other elements of tissue repair 33 , showed a significant increase in the peri-infarct area in the hcV brain compared with the no gel and gel + Vs conditions in the close vicinity of vessels ( Supplementary Fig. 7 ).
Therapeutic angiogenic materials often have a short-term angiogenic response that subsides and vessels regress as the angiogenic stimulus (for example, VEGF) is depleted 34 . HA gel + hcV resulted in a significantly increased vascular area inside the stroke cavity, whereas no significant difference between the groups was observed in the peri-infarct area (Fig. 2a,b) . Inside the infarct, the increased angiogenesis led to a vascular area greater than the contralateral side, which indicates a vascular network that is more substantial than the original network in this cortical area. After stroke, the normal process of angiogenesis leads to a tortuous and dilated vasculature 31 .
We assessed the vascular tortuosity, branching points, vessel diameter and infiltration distance within the infarct cavity of the induced vessels 35 compared to normal vessels in the contralateral side at 16 weeks. HA gel + hcV showed a lower degree and variability of vessel tortuosity and was closer to the tortuosity of normal vessels (Fig. 2c  (left) ). There was no significant difference in the number of vascular ramifications between groups (Fig. 2d (left) ). Finally, the stroke cavity with HA gel + hcV displayed a significantly reduced vascular diameter compared with HA gel + Vs (Fig. 2c (right) ), with a value close to the contralateral normal control side and a significantly greater vascular infiltration distance into the lesion site compared with any other group (Fig. 2d (right) ).
Interestingly, although no effect on the BBB permeability was observed at 2 weeks ( Supplementary Fig. 4 ), a significantly increased infarct size was found in the Vs condition ( Supplementary  Fig. 3 ), consistent with previous reports that Vs administration in stroke may worsen stroke outcome 36 . This increased stroke volume observed in the Vs condition 2 weeks after stroke is maintained at 16 weeks poststroke ( Supplementary Fig. 8 ).
hcV induces neurogenesis and axonogenesis
We tested the hypothesis that by promoting a dense and wellformed vascular bed inside the stroke cavity, the development of an accompanying neural structure would follow. Neurogenesis after stroke occurs to a limited degree as neuroblasts migrate from their origin in the subventricular zone (SVZ) to areas of damage. Neurogenesis in the present experiments was assessed by staining neuroblasts (Dcx) 10 days or 16 weeks after gel transplantation in distal MCAo stroke. The number of proliferative neuroblasts (Dcx/5-bromo-2′ -deoxyuridine (BrdU)) was significantly increased in the hcV compared with the no gel control group (Fig. 3c) . The total number of Dcx cells in the SVZ was also significantly increased in both the HA gel + hcV and HA gel + nH conditions compared with any other group. Similarly, these two conditions displayed a significantly increased number of Dcx cells along the corpus callosum, the migratory path towards the lesion, compared with any other group, with no significant difference in Articles NATure MATerIAlS the migrating distance (Fig. 3d) . These results may be due to the increased angiogenic signal in the HA gel + hcV and HA gel + nH conditions (Fig. 1d ) or due to reductions in tissue barriers at this site. The addition of VEGF did not change the inflammatory response to HA gel + nH, which continued to significantly reduce the microglial positive area and astrocytic scar thickness compared with mice injected with lcV (Gel + lcV), Vs (Gel + Vs), empty gel and no gel control 2 weeks after stroke ( Supplementary Fig. 4, 8 ). This early increase in immature neurons in the peri-infarct cortex was not sustained: at 16 weeks there were no significant differences between groups in the number of Dcx cells ( Supplementary  Fig. 9 ). These data suggest that the presence of naked heparin particles found in both the gel + nH and gel + hcV conditions induces migration of immature neuroblasts into the damaged tissue adjacent to the stroke cavity at the initial stages during tissue recovery after stroke.
We next determined if angiogenesis could promote the infiltration of axons into the stroke lesion site as it does in the normal body during development 37 . Three separate assessments were performed to assess axonogenesis at 2 and 16 weeks utilizing a marker for axons, neurofilaments (neurofilament 200 (NF200)), and to assess its density in the infarct and peri-infarct areas, neurofilament infiltration distance and neurofilament infiltration angle (a measure of the orientation of the axonal network). At both 2 weeks (Fig. 3e ,f) and 16 weeks (Fig. 3h-j) after stroke, only the hcV had significantly more neurofilament area compared with the other conditions. These axons had a significantly deeper axonal infiltration distance into the infarct, and a penetrating angle that is similar to the angle measured Data are presented using a minimum-tomaximum box plot. Each dot in the plots represents one animal and P values were determined by one-way analysis of variance (ANOVA) with a Tukey's post-hoc test. *P < 0.05, **P < 0.01, ****P < 0.0001. Scale bars, 100 µ m. NS, not significant.
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between the NF200 axons and the cortex in the contralateral side ( Fig. 3k ), which suggests that the formed axonal network in the hcV condition is structured in a similar linear pattern to that of the normal cortical axonal network. Interestingly, at 16 weeks the NF200 positive area in the hcV condition is higher than the contralateral value (dotted line) in the homologous cortex that is not affected by stroke (Fig. 3h,i ), which indicates that, similar to the formed vasculature in the hcV-treated brains, the axonal ingrowth into the stroke cavity establishes a network of connections that is greater than the underlying brain structure of the cortex.
To study further the connection of the vascular network with the formed axonal network, we co-stained vessels (Glut-1) and neurofilament networks (NF200) at 16 weeks. We found a very close association between the vessels and neurofilaments in the hcV brains (Fig. 4a,b ) with a statistically higher percent of neurofilaments that are either in direct contact with (Fig. 4c) or within 50 µ m of a vessel ( Fig. 4d) , which further confirms the role of vessels in forming a reparative neurovascular niche that leads to axonogenesis within the stroke cavity.
To prove that the observed axonogenesis was due to the revascularization of the stroke cavity and not a direct effect of VEGF on sprouting neurons 38, 39 , we blocked angiogenesis through a VEGFindependent mechanism using endostatin during days 5 to 15 after stroke and analysed the neurofilament network at 16 weeks. This approach blocks angiogenesis in this stroke-hydrogel-VEGF approach 40 . We found a significant reduction of the vascular area ( Supplementary Fig. 10a ), growth ( Supplementary Fig. 10b ) and infiltration ( Supplementary Fig. 10c ) of endostatin-injected HA + hcV mice at 16 weeks poststroke. The blockade of angiogenesis in HA gel + hcV mice is associated with a statistical reduction of the axonal network area in and around the stroke (Fig. 4a,b) , particularly in the vicinity of the vessels (Fig. 4c) , which indicates that angiogenesis is causally linked to the axonogenesis observed in the hcV condition. These results show that to induce angiogenesis into the infarct can generate an elaborate neuronal architecture within this normally fibrotic cavity. To identify the neuronal population that sends axonal projections to the stroke site of gel + hcVtreated mice, we delivered biotinylated dextran amine (BDA), a marker for bidirectional axonal tracing in the gel injection coordinates on week 16 after gel treatment (Fig. 4d) . BDA uptake was visualized fluorescently using a streptavidin-fluorochrome detection. Brain sections were co-stained with the astrocytic marker glial fibrillary acidic protein (GFAP) to visualize the lesion site. We found that neurons that send axonal projections in the injected cavity of hcV mice are located in the in the ipsilateral peri-infarct cortex, with a clear detection of retrogradely traced cell bodies up to 800 µ m distant from the site of injection.
Last, we aimed to determine whether the formed vasculature in the gel + hcV brains presents characteristics of functional maturity with both coverage with pericytes (PDGFR-β (Fig. 4e) ) and astrocyte end-feet (aquaporin-4 (aqua-4) (Fig. 4f) ). Fluorescent staining showed a strong vascular coverage with both pericytes and astrocyte end-feet, and associated with GFAP-expressing astrocyte cell bodies in the vicinity of vessels, which further indicates that, in this condition, normal brain architecture is achieved.
From an angiogenic material to functional recovery
To test whether the induced vascular and neuronal tissue in the stroke cavity is associated with functional recovery, behavioural recovery was measured after hydrogel transplantation. Photothrombotic (PT) stroke in the forelimb motor cortex causes limb-use deficits in mice for at least 16 weeks after the infarct 41 . Mice received this Data are presented using a minimum-tomaximum box plot. Each dot in the plots represents one animal and P values were determined by one-way ANOVA with a Tukey's post-hoc test. *P < 0.05, **P < 0.01, ****P < 0.0001and indicate p < 0.05 and p < 0.01, respectively versus Gel + hcV. Scale bars, 100 µ m.
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NATure MATerIAlS stroke and were transplanted 5 days later with HA gel, HA gel + Vs, HA gel + lcV and HA gel + hcV (Fig. 5a ). Limb control was measured with three different behavioural tests every 4 weeks for 16 weeks to assess the dexterity of the contralateral forelimb (cylinder test/asymmetry score (Fig. 5bi) , hindlimb (grid test/footfault (Fig. 5bii) and forepaw (pasta test/paw adjustment and time in seconds (Fig. 5biii,iv) ) in measures that reflect human motor-control patterns after stroke 42 . Stroke causes a deficit in limb motor control in exploratory rearing, gait and dexterous forepaw use that is maximal at 4 and 8 weeks after the infarct with some recovery, but still a persistent deficit, at 12 and 16 weeks. HA gel + hcV-injected animals displayed a significantly increased use of their contralateral forelimb in exploratory rearing in the cylinder task beginning 12 weeks after stroke (Fig. 5bi) and a significant decrease in the number of contralateral footfaults on the grid walk task at the same point (Fig. 5bii) . The pasta handling test showed that the HA gel + hcV condition produced a significantly reduced time to manipulate and eat a piece of pasta on weeks 8 to 16 (Fig. 5biii) , whereas it showed a significantly increased use of contralateral digits in handling the pieces of food (Fig. 5biv) . No other gel or VEGF condition was associated with this degree of enhanced functional recovery. These results indicate a dramatic decrease in limb-use deficits for the hcV condition, which suggests that the axonal network observed in the HA + hcV delivery is functionally active.
To prove that the observed functional recovery was linked to angiogenesis due to the formed axonal network in the stroke cavity, we performed two separate tests. First, we used endostatin to block angiogenesis as previously done (Supplementary Fig. 10 ). As blocking angiogenesis significantly reduced the neurofilament density and infiltration distance (Fig. 3g-j) , blocking angiogenesis should also prevent the functional improvement observed if the formed axonal network or vascular network is responsible for the observed improvement. Treatment with endostatin impaired the recovery observed in the hcV condition with a significantly decelerated recovery compared with the HA gel + hcV animals, and this in all the behavioural tasks performed (Fig. 5c) , which demonstrates that VEGF-induced angiogenesis is critical in the observed functional recovery. To test if the enhanced functional recovery in the HA + hcV condition was due to the axonal connections observed in the infarct (Fig. 5d) , we retrogradely transfected the neurons that extend these axons into the infarct (Fig. 4a,d ) by injecting an adeno-associated virus (AAV) construct that expresses a neuronal silencing receptor, hM4D DREADD 43 , directly into the infarct site. Neurons that form connections into the damaged tissue and the HA gel + hcV gel will be inhibited when clozapine-N-oxide (CNO), the ligand for hM4D, is administered. This technique has been used to silence neuronal activity in a specific area of rodent brain 43 . At week 13, a time of enhanced motor recovery in HA gel + hcV, neurons that project into the hcV gel were silenced with CNO (Fig. 5a) . Initially, HA gel + hcV-treated stroke animals showed an enhanced functional recovery, which replicated the earlier results with this gel. However, when these animals were treated with CNO the improved motor functions were lost and the animal deficit worsened (Fig. 5d) , which demonstrates that the formed axonal network is responsible for the observed functional improvement. In total, these studies indicate that HA gel + hcV promotes the development of a neurovascular brain tissue within a normally fibrotic scar and promotes functional recovery through angiogenesis and stimulated axonal ingrowth into a network of connections from adjacent brain.
Immunomodulation through naked heparin particles
The injected hcV and lcV treatments were designed to contain equal amounts of heparin and VEGF (Supplementary Fig. 1 ). Although we showed that heparin particles have a reduced blood-thinning ability compared to polymeric heparin ( Fig. 6 and Supplementary Fig. 11 ), the introduction of naked heparin particles to the hcV group Mice were injected 5 days after stroke with one of the following treatments: empty gel, gel + Vs, gel + lcV and gel + hcV. Mice were subjected to different behavioural tests (illustrated by vertical grey boxes on the timeline) on weeks 0, 1, 4, 8, 12 and 16 after stroke. b, The cylinder test was used to measure the dexterity of their contralateral forelimb (i), the grid test for the contralateral hindlimb (ii) and the pasta tests for the contralateral forepaw (iii and iv), normally sensitive to poststroke lateralized impairments. c, To determine the role of gel + hcV-induced vascularization on behavioural recovery, a supplemental set of gel + hcV animals was administered with endostatin, a VEGF-independent angiogenic inhibitor, for 10 days after the gel injection, and submitted to the same behavioural tests: cylinder, grid and pasta. d, To determine the role of gel + hcV-induced axonal growth on recovery, a supplemental set of gel + hcV animals received a brain injection of an AAV5 viral construct that expressed hM4 DREADD (designer receptors exclusively activated by a designer drug) directly in the stroke area on week 13. Transfected neurons were silenced after i. 
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complicates clinical translation. Thus, we wanted to determine if the delivery of hcV alone would perform similarly to hcV + nH. We injected mice with gels that contained only heparin particles coated with VEGF at high cluster density and removed the unloaded naked particles (hcV -nH). The results showed that, similarly to the hcV treatment, the hcV -nH treatment enhanced poststroke angiogenesis at 2 weeks (Fig. 6a,b) . This pro-angiogenic effect was maintained in the peri-infarct 16 weeks after stroke (Supplementary Fig 11a,b) .
However, the increase in angiogenesis was accompanied with an increase in inflammation (Fig. 6a,c) , characteristic of VEGF delivery in the brain and other organ systems 44 . Both the microglia area and glial scar thickness were increased significantly in the hcV -nH condition compared with hcV, showing an inflammation worse than that in the empty-gel control group (Fig. 6e) . Further, no axonal growth was observed in this group (Fig. 6d) . The pro-inflammatory effect of hcV -nH was also observed at 16 weeks, with the microglia As the injected hcV and lcV treatments were designed to contain equal amounts of heparin and VEGF, the VEGF clusterization in the hcV treatment was obtained on a low amount of heparin to leave a high amount of naked particles. To understand the contribution of these naked particles in the prorepair effect of the hcV, two supplemental groups were studied: the hcV - nH group in which naked particles from the hcV were removed, and the lcV + nH group in which additional naked particles were added to the low VEGF cluster condition. a, Fluorescent images of vessels (Glut-1), astrocytic scar (GFAP), microglia (Iba-1) and axonal neurofilaments (NF200) in and around the stroke site (*) of gel + (hcV - nH) and lcV + nH) conditions at 2 weeks poststroke. b-e, Quantitative assessment of the vascular area in the infarct (top) and the peri-infarct area (bottom) (b), microglial area in the infarct (top) and the peri-infarct area (bottom) (c), axonal area in the infarct (top) and the peri-infarct area (bottom) (d) and axonal infiltration distance (top) and astrocytic scar (bottom) (e) at 2 weeks poststroke. hcV - nH, 0.01 µ g of nH loaded with 200 ng of VEGF; lcV, 1 µ g of nH loaded with 200 ng of VEGF and 0.99 µ g of unloaded nH. Data are presented using a minimum-tomaximum box plot. Each dot in the plots represents one animal and P values were determined by one-way ANOVA with a Tukey's post-hoc test. **P < 0.01, ***P < 0.001, ***P < 0.0001. Data represent the average. Scale bar, 100 µ m.
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NATure MATerIAlS area and scar thickness maintained significantly higher than in hcV ( Supplementary Fig 11c,e) . The results obtained with the hcV -nH conditions show that axonal formation that follows therapeutic angiogenesis requires an immune modulation of the injury-induced inflammation. The absence of poststroke immune modulation results in vasculature that is not followed by tissue repair. Similarly, we tested whether the addition of naked heparin particles to lcV, a VEGF cluster group that did not show a prorepair effect in the brain, would increase its beneficial effects. This experimental condition, lcV + nH, was tested for the same repair characteristics at 2 (Fig. 6 ) and 16 weeks (Supplementary Fig. 11 ). The results show that the lcV + nH treatment did not promote vascular (Fig. 6b) or axonal growth (Fig. 6d) , and did not reduce the microglial inflammation (Fig. 6c) or the scar thickness (Fig. 6e) 2 weeks after stroke. The same results were observed at 16 weeks poststroke ( Supplementary Fig 11-d) . The results obtained with lcV + nH show that the combination of VEGF and naked particles is not enough to promote brain repair, as the therapeutic effect of heparin particles is only observed with high VEGF clusters.
To investigate the effect of nH on inflammatory and anti-inflammatory cytokine levels after stroke, a multiplex enzyme linked immunosorbent assay (ELISA) was performed. Mice were stroked and injected with gel + nH 5 days poststroke. After gel transplantation, the infarct core with the injected gel was harvested at 3 and 10 days and quantified for their levels of cytokines (tumour-necrosis factor-α (TNF-α ), interleukin-6 (IL-6), interferon-γ (IFN-γ ), IL-1α , IL-1β , IL-2, IL-4 and IL-10). We found that gel + nH significantly decreased the brain concentration of TNF-α 3 days after the gel injection (P = 0.0076). At this time point, gel + nH does not show any significant difference with the no-stroke condition (Supplementary Note 2 and Supplementary Fig. 12 ).
Conclusion
The stroke cavity is a fibrotic region devoid of neurons and with a sparse, disordered vasculature. The cavity represents the tissue lost after stroke and is associated with functional disability in stroke patients. This report shows that engineering a VEGF-containing hydrogel biomaterial and injecting it directly within the stroke cavity induces the formation of a vascular and neuronal structure that leads to behavioural improvement. HA gel + hcV induced the formation of a robust, mature and highly developed vascular bed within the stroke cavity and patterned axonal ingrowth along these vessels. This vascular bed is mature, as compared to the normal vascular structure in the cortex, in its morphology and pericyte coverage. This is unexpected in a traditional delivery of VEGF in the brain 32 and indicates that the clustered nanoparticle presentation of VEGF in the hydrogel promotes elements of normal vascular development. This distinctive vascular development in hydrogelpresented nanoparticle-clustered VEGF is supported by the differential VEGFR2 (vascular endothelial growth factor receptor 2) phosphorylation and downstream p38 signalling of clustered VEGF. This hydrogel also modifies the adjacent peri-infarct tissue by reducing microglia activation and the size of the reactive astrocyte border, and by promoting in-migration of immature neurons from the SVZ. HA + hcV hydrogels promote vascular ingrowth into the infarct cavity and an accompanying axonal network. These formed axons inside the stroke cavity are tightly physically associated with the generated vascular network, and selective blockade of the vascular ingrowth blocks the development of this axonal network inside the cavity. These findings support a process of coordinated vascular and axonal growth in a developing neural tissue inside a normally fibrotic brain scar. In the developing body, and particularly in skin, the development of the vascular and neuronal networks is tightly coordinated through shared molecular signalling systems, such as slits, semaphorins, netrins and VEGF 45 . In the present study, the co-delivery of nanoparticle-clustered VEGF and nH was sufficient to induce this ingrowth and co-patterning of vascular and neuronal systems, but it is likely to have done so by initiating a process that may be locally sustained by these other signalling systems.
Although the anticoagulant properties of heparin are well established, increasing evidence indicates that heparin presents many anti-inflammatory effects linked to its ability to block leukocyte adhesion to the vessel wall 46 and to stabilize chemokine and growth-factor gradients 47 , but it also acts as a reservoir of heparinbinding cytokines 48 . Here we hypothesize that the immunomodulation properties of naked particles result from its ability to bind and decrease brain levels of stroke-induced pro-inflammatory cytokine TNF-α directly at the lesion site. Moreover, the high inflammation found in lcV, in which all the heparin particles are bound to VEGF, further indicates that the anti-inflammatory properties of heparin particles are exclusively observed in their unbound state. VEGF delivery has been associated with increased inflammation, which lowers the efficacy and increases the adverse effects 44 . Here we show that naked heparin particles can counterbalance the inflammatory effect of VEGF and lead to the formation of a prorepair environment that leads to brain tissue formation de novo.
The injection of a hydrogel into the stroke cavity has been tested in large animal stroke models 20 , and provides a tractable way to approach the postinfarct brain without damaging or manipulating viable tissues around the infarct, which are a site of substantial repair 15 . This combination of direct production of a neurovascular structure in the infarct cavity and the modulation of inflammatory, scar and neural stem cell responses in the adjacent brain position this approach as unique in the field of neural repair.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41563-018-0083-8.
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Methods
Heparin nanoparticle synthesis and VEGF binding. Heparin (from porcine intestinal mucosa (Alfa Aesar)) was modified with p-azidobenzyl hydrazide as previously described 49 . The remaining carboxylic acid groups on heparin were then conjugated with N-(3-aminopropyl)methacrylamide in 27 molar excess through EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide) coupling chemistry overnight in PBS buffer, dialysed against distilled water and lyophilized. The final product was dissolved in a 100 mg ml -1 solution of sodium acetate at pH 4, mixed with Tween-80 and Span-80 (8% hydrophilic-lipophilic balance) and sonicated to form nanoparticles. A radical polymerization was initiated as previously described 49 . A total concentration of 20 μ g ml -1 VEGF (Genentech) was mixed with concentrations of nH that ranged from 0.1 to 0.001 mg ml -1 to form different packing densities of VEGF onto the particle's surface, incubated overnight and exposed to ultraviolet light (365 nm) for 10 min to bind VEGF covalently to heparin particles. The VEGF nanoparticles were washed from excess with 0.05% Tween-20, and then with PBS, using a 100 kD molecular weight cut-off dialysis unit. The washes were collected and an ELISA and dot blot were performed to estimate the amount of VEGF bound to the nanoparticles by subtracting the washes from the total amount of VEGF mixed.
Heparin nanoparticle characterization. Dynamic light scattering (DLS) was used to characterize the Z-average (diameter) and polydispersity index of nH after each preparation step. Samples were analysed by a Malvern Zetasizer with ten runs performed, each of three measurements. To confirm the results obtained by DLS, transmission electron microscopy (TEM) with a T12 Quick CryoEM was performed on heparin particles (1 mg ml -1 ) using a carbon-coated copper grid (300 mesh). The nanoparticles were negatively stained by a 2 wt% phosphotungstic acid solution.
ELISA and dot blot. The amount of VEGF immobilized onto nanoparticles in the different clustering conditions was measured using a standard ELISA technique as previously described 50 . A dot blot was also realized to confirm the ELISA results. A 2 µ l drop of the sample was deposited on a nitrocellulose membrane. A blocking buffer of BSA (1% in PBS) was used before adding the biotinylated detection antibody, followed by streptavidin-horseradish peroxidase. The samples were then visualized using chemifluorescence (enhanced chemiluminescent detection reagents (GE Healthcare)) using a Molecular Imager Chemi Doc XRS and scanner (Bio Rad). The stained membrane images were analysed with Image Lab software.
VEGFR-2 phosphorylation assay.
Human umbilical vein endothelial cells (HUVECs (CC-2519 (Lonza))) were cultured as previously described 29 .
RNA isolation and quantitative real-time PCR (qPCR).
HUVECs were purhased from Lonza (cat no. C2519A) and used for four passages before a new validated cell stock was purchased from the same vendor. HUVECs were grown up to 70% confluency in complete EGM media (Lonza). Cells were submitted to serum deprivation for 5 h before exposure to fetal bovine serum (FBS) basal EGM-2 media at different time periods (2, 4 and 6 h). Cells were trypsinized and the cell pellet was collected. Lysis buffer from the RNAqueous Micro Total RNA isolation kit (Ambion (Life Technologies)) was immediately added to cell pellet. RNA concentration was evaluated by ultraviolet absorbance (λ = 260 nm). Reverse transcription was carried out by loading 0.25 μ g of RNA per reaction of the iScript Advanced cDNA synthesis kit (Bio-Rad). qPCR was carried out using 10 ng of cDNA per reaction of the Maxima SYBR Green/ROX qPCR master mix (Thermo Scientific) following the manufacturer's recommended protocol for three-step cycling using the StepOnePlus real-time PCR system (Applied Biosystems). Every 20 μ l reaction contained 5 μ l of cDNA, 12.5 μ l o SYBR Green master mixes (Life Technologies), 250 nM forward, reverse primers and nuclease-free water. Threshold cycles (CTs) were evaluated by the bundled software and the expressionfold change was calculated using the delta-delta CT method assuming 100% efficiency. GAPDH (glyceraldehyde 3-phosphate dehydrogenase) was used as the housekeeping gene.
Proliferation assay. The proliferation rate of HUVEC cells exposed to different clusters of VEGF was evaluated using a Cell Proliferation Assay Kit (CyQUANT (Invitrogen)). Briefly, cells were grown in complete EGM-2 media in a 96-well plate for 2-4 h for cell attachment and exposed to VEGF nanoparticles of different cluster density in basal EBM media with 2% FBS (Lonza) and compared to a negative control condition that contained no VEGF. After 2 days of culture, cells were lysed and the relative fluorescence was measured at 485 nm excitation and 528 nm emission. The data are expressed as relative fluorescence to a condition in which cells were exposed only to heparin particles.
Tail-vein bleeding assay. C57BL/6 male mice of 8-12 weeks (Jackson Laboratories) were put under isoflurane anaesthesia (2-2.5% in a 70% N 2 O/30% O 2 mixture), then placed on a warming pad and injected intravenously with heparin, heparin particles or saline (4 U kg -1 , 50 μ l). After 30 min, the lateral vein was incised transversally over a position that corresponded to a diameter of 2.5 mm. The tail was then immersed in warm PBS (37 °C) in a conical tube until the vein stopped bleeding (tail-vein bleeding time within seconds).
HA modification and hydrogel gelation. HA (60,000 Da (Genzyme)) was functionalized as previously described 13 .
Gelation. The hydrogel was made as previously described by our laboratory 51 . We had already found that clustered bioactive signals, such as the adhesion peptide Arg-Gly-Asp (RGD) results in significant differences in cell behaviour when encapsulated inside three-dimensional HA 52 . The highest degree of cell spreading, integrin expression and proliferation of encapsulated mouse mesenchymal stem cells was obtained with a ratio of 1.17 mol RGD-reacting HA for 1 mol RGD. The RGD peptide was dissolved in 0.3 M HEPES and added to 16% of the total HA-AC (hyaluronic acid-acrylate) required to obtain a degree of clustering of 1.17, and reacted for 20 min at room temperature before being added to the rest of non-RGD reacting HA-AC. A total of 200 ng of soluble (gel + Vs) or heparin nanoparticlebound VEGF 165 (gel + hcV and gel + lcV) was added to the gel precursor solution.
Animal experiment design. Animal procedures were performed in accordance with the US National Institutes of Health Animal Protection Guidelines and approved by the Chancellor's Animal Research Committee as well as the UCLA Office of Environment Health and Safety. C57BL/6 male mice of 8-12 weeks (Jackson Laboratories) were used in the study. Two stroke models were performed: a permanent and distal MCAo and a photothrombotic (PT) stroke. The MCAo model closely simulates human ischaemic stroke and its peri-infarct penumbra 53 as approximately 70% of human infarcts originate from the MCA. In addition, this model is considered suitable for the study of ischaemia-induced cell death, inflammation and BBB damage in the brain, and has therefore been used in the majority of studies that address poststroke repair mechanisms, such as neurogenesis and angiogenesis 54 . This model was chosen for the 2 week time point to evaluate the effect of the gel + hcV treatment on vascularization. However, because the permanent and distal MCAo model does not induce a long-term neurological deficit, the PT model was used to assess the neurological deficit for 16 weeks.
MCAo stroke model. The MCAo model was induced under 2% anaesthesia by exposing and occluding with the electrocoagulation of the anterior branch of the distal left MCA through a craniotomy over the parietal cortex. The MCAoinduced ischaemic cellular damage was localized on the somatosensory and motor cortex 55 and was chosen because of the high revascularization process after stroke in this region 56, 57 .
PT stroke model. PT stroke was induced using a intraperitoneal (i.p.)-injected light-sensitive dye as previously described 58 . Briefly, mice were positioned in a stereotaxic instrument and administered Rose Bengal (10 mg ml -1 i.p.) and the closed skull at the stereotaxic coordinate 1.5 mm medial/lateral was illuminated with a white light for 18 min.
Hydrogel and VEGF intracranial transplantation. At 5 days poststroke surgery, 6 μ l of RGD-functionalized HA hydrogel that contained the different forms of VEGF were injected directly into the stroke cavity through a 30-gauge needle attached to a 25 μ l Hamilton syringe (Hamilton). A syringe pump maintained the infusion rate at 1 μ l min -1 in the following coordinates: anterior-posterior = 0.26 mm, medial-lateral 59 = 3 mm and dorso-ventral = 1 mm and 1.5 mm for MCAo and PT mice, respectively. The control group was injected with an empty RGD-functionalized gel (empty gel). The time point for VEGF injection was selected according to published literature on on the time frame of VEGF upregulation in the stroke brain and the peak of the peri-infarct microvascular density 60 . At 10 days after hydrogel transplantation, animals were injected i.p. with BrdU (Sigma) at a concentration of 100 mg kg -1 , 4 and 2 h before euthanasia to assess the cell proliferation.
Mouse tissue processing and immunohistochemistry. At 2 weeks poststroke (10 days after transplantation), mice were transcardially perfused with 40 ml of 4% (wt/vol) paraformaldehyde (PFA). Brains were harvested and postfixed in 4% PFA overnight and immersed in 30% sucrose for 2 days for cryoprotection. Tangential sectioning of frozen brains (30 μ m thick) was obtained using a cryostat and placed on gelatin-coated glass slides. Immunohistochemistry includes washing steps using PBS and permeabilization/blockage using Triton (0.3%) and normal donkey serum (10%). Primary antibodies were as follows: rabbit anti-Glut-1 (1:200 (Abcam)) for vascular endothelial cells; goat anti-PDGFR-β (1:400 (R&D Systems)) for pericytes; goat anti-Dcx) (C18, 1:500 (Santa Cruz Biotechnology)) for subventricular neural progenitor cells; rat anti-BrdU (1:300 (Abcam)); rat anti-GFAP (1:400 (Zymed)) for astrocytes; rabbit antimicroglial-specific Iba-1 (1:250 (Wako Pure Chemical Industries)) for microglial cells; rabbit anti-NF200 (1:100 (Sigma-Aldrich)), mouse anti-angiopoietin-2 (1:100 (Abcam)), rabbit anti-aqua-4 (1:250 (Abcam)). Primary antibodies were incubated overnight at + 4 °C followed by a fluorescently labelled secondary antibody (1:1,000 (Jackson ImunoResearch)) for 1 h at room temperature. Cell nuclei were labelled using 4′ ,6-diamidino-2-phenylindole (DAPI, 1:2,000 (Invitrogen)) for 10 min, followed by a step of dehydration in ethanol and dewaxing in xylene. For BrdU staining, sections were incubated with 2 N HCl and sodium borate buffer (pH 8.4) before the addition of the primary antibody Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist.
Experimental design 1. Sample size
Describe how sample size was determined. The sample size was determined by using a statistical power analysis that compares the mean value and standard deviation of a selected experiment (microglia surface % in the peri-infarct area 2 weeks after stroke) in a selected animal condition (gel only) performed in a pilot study, with a previously published finding on the same experiment, condition and time point (Lam, J et al, Adv Funct Mater 2014). The alpha value (Type 1 error) was fixed at the level of 5% (P = 0.05) and the power at 80%.
Data exclusions
Describe any data exclusions.
No data was excluded from the study, at any time point and in any condition.
Replication
Describe whether the experimental findings were reliably reproduced.
The reproducibility of the findings was tested by comparing the data obtained from 2 different researchers who analyzed the results blindly to experimental conditions. The two set of results were then statistically compared to assure that no significant difference was found.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Animals were randomly selected for each experimental condition as follows. During the surgical procedure, all animals from a cage (4 total) were named with the cage and animal number in the chronological order of stroke-inducing surgery using a systematic ear-punching protocol for identification (Cage 1-Mice 1). At the moment of delivery, each treatment was attributed to a randomly selected animal from one of the different cages. The list of animals and experimental condition was then noted and saved by the researcher.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
After sacrifice and during tissue processing, a different researcher attributed a random number to each sample and kept the first researcher blind to all conditions until statistical analysis was done. Thus, tissue processing and data analysis were both performed without any possible identification of the studied samples.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
Prism (version 6.0b, GraphPad, La Jolla California, USA) was used for statistical analysis and Image J (ImageJ v1.43, Bethesda, Maryland, USA) was used for fluorescent image analysis.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
All the material used in this study are commercially available without any restriction, and used in routine in research.
